HealthEquity, Inc.
General ticker "HQY" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $7.8B (TTM average)
HealthEquity, Inc. follows the US Stock Market performance with the rate: 22.5%.
Estimated limits based on current volatility of 2.1%: low 95.07$, high 99.07$
Factors to consider:
- Total employees count: 2814 (-9.8%) as of 2026
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Diminished tax benefits, Cybersecurity threats, Healthcare funding reduction, Internal control weaknesses, Third-party risks
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [72.46$, 107.70$]
- 2027-01-31 to 2028-01-31 estimated range: [73.10$, 108.93$]
Financial Metrics affecting the HQY estimates:
- Negative: with PPE of 21.0 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 24.55 > 18.77
- Negative: negative Industry operating cash flow (median)
- Positive: 0.28 < Operating cash flow per share per price, % of 6.29
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 5.99
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating income (median)
Short-term HQY quotes
Long-term HQY plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $999.59MM | $1,199.77MM | $1,313.43MM |
| Operating Expenses | $881.89MM | $1,037.44MM | $990.97MM |
| Operating Income | $117.70MM | $162.33MM | $322.46MM |
| Non-Operating Income | $-42.66MM | $-46.30MM | $-45.02MM |
| Interest Expense | $55.45MM | $60.63MM | $57.13MM |
| R&D Expense | $218.81MM | $239.51MM | $262.51MM |
| Income(Loss) | $75.04MM | $116.03MM | $277.43MM |
| Taxes | $19.33MM | $19.33MM | $62.23MM |
| Net Income(Loss)* | $55.71MM | $96.70MM | $215.20MM |
| Stockholders Equity | $2,035.02MM | $2,114.91MM | $2,107.20MM |
| Assets | $3,163.79MM | $3,448.55MM | $3,380.33MM |
| Operating Cash Flow | $242.83MM | $339.86MM | $457.09MM |
| Capital expenditure | $46.07MM | $2.08MM | $1.97MM |
| Investing Cash Flow | $-46.07MM | $-505.45MM | $-47.14MM |
| Financing Cash Flow | $-47.04MM | $57.57MM | $-386.98MM |
| Earnings Per Share** | $0.65 | $1.11 | $2.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.